Automate Your Wheel Strategy on CRON
With Tiblio's Option Bot, you can configure your own wheel strategy including CRON - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CRON
- Rev/Share 0.3537
- Book/Share 2.9109
- PB 0.6859
- Debt/Equity 0.0017
- CurrentRatio 27.7954
- ROIC -0.0612
- MktCap 736150290.0
- FreeCF/Share -0.0198
- PFCF -96.8405
- PE 14.7938
- Debt/Assets 0.0016
- DivYield 0
- ROE 0.0463
- Rating A
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 4
- D/E Score 4
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
No ratings available. |
News
Marijuana Stocks To Watch With Strong Market Potential
Published: June 06, 2025 by: MarijuanaStocks
Sentiment: Positive
At one time the hype on various cannabis stocks was enough to send the market into an upward frenzy. Now not so much however the perspective on the cannabis sector has changed. A once short-term way to make gains is now looking like a promising long-term investment. There is still a large amount of uncertainty and even more with Donald Trump in office. It has been the success of the legal market that has kept people looking for marijuana stocks to buy.
Read More
Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference
Published: June 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the TD Cowen 9th Annual Future of the Consumer Conference on Wednesday, June 4, 2025, at 3:30 p.m. EST.
Read More
Cronos Group: Industry Fortress Balance Sheet And FCF Create A Solid Upside Potential
Published: May 22, 2025 by: Seeking Alpha
Sentiment: Positive
Cronos Group boasts a strong net cash position nearly equal to its market cap, offering downside protection and operational flexibility. Leading brands like Spinach and Lord Jones have secured top market shares in key cannabis segments, driving consistent revenue growth. The company has achieved free cash flow positivity, signaling the end of its capital-intensive phase and disciplined capital allocation.
Read More
Top Marijuana Stocks In A Volatile Market
Published: May 21, 2025 by: MarijuanaStocks
Sentiment: Neutral
Right now, cannabis companies are still reporting Q1 2025 earnings, and for most things, are looking good. It is undeniable how well the cannabis industry is doing, even as the road ahead is still a tough one. Profits are being made and growth is occurring throughout the sector.
Read More
Top 3 Marijuana Stocks For Better Investing 2025
Published: May 09, 2025 by: MarijuanaStocks
Sentiment: Negative
The current state of marijuana stocks could keep some people discouraged. With no federal reform or bills to ease tax burdens and improve banking access, this has led to a downtrend. A volatile wave of downward trading has plagued the sector for some time. People see that money is being made for legal operators, but still, no one feels as safe and protected as they should be.
Read More
Cronos Group Inc. (CRON) Q1 2025 Earnings Call Transcript
Published: May 08, 2025 by: Seeking Alpha
Sentiment: Neutral
Cronos Group Inc. (NASDAQ:CRON ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Terry Doucet - General Counsel & Corporate Secretary Mike Gorenstein - Chairman, President & Chief Executive Officer Anna Shlimak - Chief Financial Officer Conference Call Participants Bill Kirk - ROTH Capital Partners Operator Good morning. My name is Jacinda [ph] and I will be your conference operator today.
Read More
Cronos Group Reports 2025 First Quarter Results
Published: May 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis
Read More
3 Marijuana Stocks For The Long Term Investing
Published: May 02, 2025 by: MarijuanaStocks
Sentiment: Positive
Marijuana stocks hold lots of potential for home-run investments in the future. In 2018, most pot stocks saw their first wave of the green rush. Yet over the last several years, this has not been the case and things have changed drastically. Still, the way companies are keeping up with. Market demand profits and revenue are steadily rising. However, this success has played very little in how most marijuana stocks trade.
Read More
3 Canadian Marijuana Stocks For Long-Term Investing
Published: April 04, 2025 by: MarijuanaStocks
Sentiment: Positive
Marijuana stock investors are torn between several paths. With how volatile the space is, much of the sector is trading at low price points. It is almost safe to say that more than half of those who have shares in a cannabis company are down. But that doesn't mean that it will stay that way forever. The overall cannabis industry continues to flourish even though that same success doesn't impact the public sector as it used to.
Read More
Cronos Stock: Win Big Or Lose All
Published: March 23, 2025 by: Seeking Alpha
Sentiment: Positive
I maintain a 'strong buy' rating for Cronos, despite regulatory headwinds, due to its strong fundamentals and potential for multibagger returns. Cronos has shown positive progress with a robust cash buffer, 35% revenue growth, reduced EBITDA losses, and positive operating cash flows in FY 2024. International expansion, strategic investments, and a focus on R&D are key drivers for Cronos' sustained top-line growth and market diversification.
Read More
3 Canadian Marijuana Stocks To Watch For Future Gains 2025
Published: March 19, 2025 by: MarijuanaStocks
Sentiment: Neutral
Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U.S., can greatly affect how shareholders think. Additionally, oversupply in certain regions has led to falling prices, which negatively affects revenue for companies in the sector. This has created a volatile sector where the trading behavior of the most public companies is more on the low end.
Read More
Top Marijuana Stocks To Know In Today's Stock Market 2025
Published: March 05, 2025 by: MarijuanaStocks
Sentiment: Positive
As the cannabis industry continues to grow, more companies are expanding their product lines beyond traditional flower sales. This includes edibles, oils, and wellness products, attracting a broader consumer base. The demand for more cannabis products is helping bridge some gaps between existing players. For example, when companies partner in some way to create and release products, it often has a positive impact all the way around for the companies.
Read More
Cronos Group Inc. (CRON) Q4 2024 Earnings Call Transcript
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Neutral
Cronos Group Inc. (NASDAQ:CRON ) Q4 2024 Results Conference Call February 27, 2025 8:30 AM ET Company Participants Anna Shlimak - Chief Strategy Officer Mike Gorenstein - Chairman, President and Chief Executive Officer James Holm - Chief Financial Officer Operator Good morning. My name is Antoine, and I will be your conference operator today.
Read More
Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
TORONTO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 fourth-quarter and full-year earnings conference call on Thursday, February 27, 2025 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.
Read More
About Cronos Group Inc. (CRON)
- IPO Date 2018-02-27
- Website https://www.thecronosgroup.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Mr. Michael Ryan Gorenstein J.D.
- Employees 459